
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>H5</td><td>1</td><td>Amlodipine</td><td>Etravirine</td><td>The metabolism of Etravirine can be decreased when combined with Amlodipine.</td></tr><tr><td>H5</td><td>1</td><td>Amlodipine</td><td>Tenofovir alafenamide</td><td>The metabolism of Tenofovir alafenamide can be decreased when combined with
Amlodipine.</td></tr><tr><td>H5</td><td>1</td><td>Dolutegravir</td><td>Etravirine</td><td>The serum concentration of Dolutegravir can be decreased when it is combined
with Etravirine.</td></tr><tr><td>H5</td><td>1</td><td>Dolutegravir</td><td>Fostemsavir</td><td>Fostemsavir may decrease the excretion rate of Dolutegravir which could result
in a higher serum level.</td></tr><tr><td>H5</td><td>1</td><td>Dolutegravir</td><td>Rosuvastatin</td><td>The excretion of Rosuvastatin can be decreased when combined with Dolutegravir.</td></tr><tr><td>H5</td><td>1</td><td>Dolutegravir</td><td>Tenofovir alafenamide</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Dolutegravir.</td></tr><tr><td>H5</td><td>1</td><td>Etravirine</td><td>Acetylsalicylic acid</td><td>The metabolism of Acetylsalicylic acid can be decreased when combined with
Etravirine.</td></tr><tr><td>H5</td><td>1</td><td>Etravirine</td><td>Tenofovir alafenamide</td><td>The metabolism of Tenofovir alafenamide can be increased when combined with
Etravirine.</td></tr><tr><td>H5</td><td>1</td><td>Fostemsavir</td><td>Rosuvastatin</td><td>The serum concentration of Rosuvastatin can be increased when it is combined
with Fostemsavir.</td></tr><tr><td>H5</td><td>1</td><td>Fostemsavir</td><td>Tenofovir alafenamide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Fostemsavir.</td></tr><tr><td>H5</td><td>1</td><td>Rosuvastatin</td><td>Etravirine</td><td>The metabolism of Rosuvastatin can be increased when combined with Etravirine.</td></tr><tr><td>H5</td><td>1</td><td>Rosuvastatin</td><td>Tenofovir alafenamide</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Rosuvastatin.</td></tr><tr><td>H5</td><td>1</td><td>Silodosin</td><td>Amlodipine</td><td>The risk or severity of orthostatic hypotension and dizziness can be increased
when Amlodipine is combined with Silodosin.</td></tr><tr><td>H5</td><td>1</td><td>Silodosin</td><td>Dolutegravir</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Silodosin.</td></tr><tr><td>H5</td><td>1</td><td>Silodosin</td><td>Fostemsavir</td><td>The serum concentration of Fostemsavir can be increased when it is combined with
Silodosin.</td></tr><tr><td>H5</td><td>1</td><td>Tenofovir alafenamide</td><td>Acetylsalicylic acid</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Acetylsalicylic acid.</td></tr><tr><td>H5</td><td>1</td><td>Zofenopril</td><td>Acetylsalicylic acid</td><td>The therapeutic efficacy of Zofenopril can be decreased when used in combination
with Acetylsalicylic acid.</td></tr><tr><td>H5</td><td>1</td><td>Zofenopril</td><td>Amlodipine</td><td>Amlodipine may increase the hypotensive activities of Zofenopril.</td></tr><tr><td>H5</td><td>1</td><td>Zofenopril</td><td>Silodosin</td><td>The risk or severity of orthostatic hypotension and dizziness can be increased
when Zofenopril is combined with Silodosin.</td></tr></tbody></table></div>
